Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells.
作者： Y Zhang , B Zhang , A Zhang , Y Zhao , J Zhao
DOI: 10.6061/CLINICS/2012(09)18
关键词: Sorafenib 、 Internal medicine 、 Apoptosis 、 Carcinoma 、 Growth inhibition 、 Medicine 、 Hepatocellular carcinoma 、 Nude mouse 、 Vitamin K2 、 Cancer research 、 Endocrinology 、 Cell growth
摘要: … Vitamin K2 is nearly non-toxic to humans and has been shown to inhibit the growth of hepatocellular carcinoma. In this study, we evaluated the effects of a combination of sorafenib and …
clinicsjournal.com参考文章(32)
Haruhiko Yoshida, Yasushi Shiratori, Masatoshi Kudo, Shuichiro Shiina, Toshihiko Mizuta, Masamichi Kojiro, Kyosuke Yamamoto, Yukihiro Koike, Kenichi Saito, Nozomu Koyanagi, Takao Kawabe, Seiji Kawazoe, Haruhiko Kobashi, Hiroshi Kasugai, Yukio Osaki, Yasuyuki Araki, Namiki Izumi, Hiroko Oka, Kunihiko Tsuji, Joji Toyota, Toshihito Seki, Toshiya Osawa, Naohiko Masaki, Masao Ichinose, Masataka Seike, Akihisa Ishikawa, Yoshiyuki Ueno, Kazumi Tagawa, Ryoko Kuromatsu, Shotaro Sakisaka, Hiroshi Ikeda, Hidekatsu Kuroda, Hiroyuki Kokuryu, Tatsuya Yamashita, Isao Sakaida, Tetsuo Katamoto, Kentaro Kikuchi, Minoru Nomoto, Masao Omata, Effect of vitamin K2 on the recurrence of hepatocellular carcinoma. Hepatology. ,vol. 54, pp. 532- 540 ,(2011) , 10.1002/HEP.24430
Flair Jose Carrilho, Luciana Kikuchi, Fernanda Branco, Carlos Sandoval Goncalves, Angelo Aves de Mattos, None, Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil Clinics. ,vol. 65, pp. 1285- 1290 ,(2010) , 10.1590/S1807-59322010001200010
Nuh N. Rahbari, Arianeb Mehrabi, Nathan M. Mollberg, Sascha A. Müller, Moritz Koch, Markus W. Büchler, Jürgen Weitz, Hepatocellular carcinoma: current management and perspectives for the future. Annals of Surgery. ,vol. 253, pp. 453- 469 ,(2011) , 10.1097/SLA.0B013E31820D944F
Meng Ma, Xian-Jun Qu, Guo-Ying Mu, Ming-Hui Chen, Yan-Na Cheng, Norihiro Kokudo, Wei Tang, Shu-Xiang Cui, Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin. Chemotherapy. ,vol. 55, pp. 28- 35 ,(2009) , 10.1159/000167022
Yong-Song Guan, Qing He, Sorafenib: activity and clinical application in patients with hepatocellular carcinoma. Expert Opinion on Pharmacotherapy. ,vol. 12, pp. 303- 313 ,(2011) , 10.1517/14656566.2011.546346
Toh Kanamori, Masahito Shimizu, Masataka Okuno, Rie Matsushima-Nishiwaki, Hisashi Tsurumi, Soichi Kojima, Hisataka Moriwaki, Synergistic growth inhibition by acyclic retinoid and vitamin K2in human hepatocellular carcinoma cells Cancer Science. ,vol. 98, pp. 431- 437 ,(2007) , 10.1111/J.1349-7006.2006.00384.X
Hitoshi Yoshiji, Ryuichi Noguchi, Masahisa Toyohara, Yasuhide Ikenaka, Mitsuteru Kitade, Kosuke Kaji, Masaharu Yamazaki, Junichi Yamao, Akira Mitoro, Masayoshi Sawai, Motoyuki Yoshida, Masao Fujimoto, Tatsuhiro Tsujimoto, Hideto Kawaratani, Masahito Uemura, Hiroshi Fukui, Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma Journal of Hepatology. ,vol. 51, pp. 315- 321 ,(2009) , 10.1016/J.JHEP.2009.04.011
Josep M. Llovet, Updated treatment approach to hepatocellular carcinoma Journal of Gastroenterology. ,vol. 40, pp. 225- 235 ,(2005) , 10.1007/S00535-005-1566-3
Judith Markovits, Ziqiu Wang, Brian I Carr, Te Ping Sun, Pierre Mintz, Marc Le Bret, Cheng-Wen Wu, Felicia Y.-H Wu, Differential effects of two growth inhibitory K vitamin analogs on cell cycle regulating proteins in human hepatoma cells. Life Sciences. ,vol. 72, pp. 2769- 2784 ,(2003) , 10.1016/S0024-3205(03)00188-7
Gang Wei, Meifang Wang, Terry Hyslop, Ziqiu Wang, Brian I. Carr, Vitamin K enhancement of sorafenib‐mediated HCC cell growth inhibition in vitro and in vivo International Journal of Cancer. ,vol. 127, pp. 2949- 2958 ,(2010) , 10.1002/IJC.25498